The SARS-CoV-2 Pandemic and Cancer Trials Ireland: Impact, Resolution and Legacy

by Carragher, F., Connolly, R.M, Hennessy, B.T, Marron, J., McDermott, R.S, Mulroe, E., Murphy, V., O’reilly, S., Rogan, K., Shannon, A.M, Tucker, L.
Published 2022

Cardiac cycle: an observational/interventional study protocol to characterise cardiopulmonary function and evaluate a home-based cycling program in children and adolescents born ex...

by Cheong, J.L.Y, Cheung, M.M.H, Clarke, M.M, Mynard, J.P, Willis, C.E
Published 2022

Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial

by Hashim, N.M, Huri, H.Z, Ibrahim, L., Saiman, M.Z, Tee, K.B, Zakaria, Z.H
Published 2022

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

by Aberle, J.H, Blüml, S., Burgmann, H., Haslacher, H., Jaeger, U., Koblischke, M., Porpaczy, E., Schneider, L., Schubert, L., Tobudic, S., Winkler, F., Winkler, S.
Published 2022

Parallel-group, randomised, controlled, non-inferiority trial of high-flow nasal cannula versus non-invasive ventilation for emergency patients with acute cardiogenic pulmonary oed...

by Monsomboon, A., Praphruetkit, N., Ruangsomboon, O.
Published 2022

COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemic

by D'Arcy, C., Graham, E., Larson, K., Levenstein, M., Li, R., Neumann, S., Rockhold, F., Sim, I., von Isenburg, M., Zuckerman, D.
Published 2022

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction

by Ballantyne, C.M, Bhatt, D.L, Brinton, E.A, Doyle, R.T., Jr, Gaba, P., Gibson, C.M, Giugliano, R.P, Granowitz, C., Jacobson, T.A, Jiao, L., Juliano, R.A, Ketchum, S.B, Martens, F.M.A.C, Miller, M., Steg, P.G, Tardif, J.-C, the REDUCE-IT Investigators
Published 2022

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectation...

by Boquoi, A., Fenk, R., Germing, U., Kobbe, G., Mohring, A., Nachtkamp, K., Rings, V., Savickaite, I., Strapatsas, J., Zukovs, R.
Published 2022

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlle...

by Chandran, S., Chataway, J., Colville, S., Dakin, R.S, Elliott, E., Gregory, J.M, Macleod, M.R, Mehta, A.R, Newton, J., Pal, S., Parker, R.A, Parmar, M.K.B, Stallard, N., Stavrou, M., Steven, M., Swingler, R.J, Weir, C.J, Williamson, J., Wong, C.
Published 2022

Surgical Clinical Trials in India: Underutilized Opportunities

by Agarwal, P., Sharma, D., Yadav, S.K
Published 2022

Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose

by Schaefer, B., Wolf, M., Zoller, H.
Published 2022

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group

by Baumer, N.T, Becker, M.L, Capone, G.T, Egan, K., Fortea, J., Handen, B.L, Head, E., Hendrix, J.E, Litovsky, R.Y, Rafii, M.S, Strydom, A., Tapia, I.E
Published 2022

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

by Adjei, A.A, Aggarwal, C., Antonia, S., Arnaldez, F.I, Atkinson, V., Baughman, J., Birnbaum, A., Bonvini, E., Cavallo, R., Cohen, R.B, Ferris, R.L, Ganju, V., Goldberg, S.M, Hauke, R., Joshua, A.M, Kalebasty, A.R, Kaul, S., Lakhani, N.J, Lou, Y., Moore, P.A, P Zandberg, D., Peng, L., Prawira, A., Rahma, O., Seetharam, M., Tolcher, A., Vogelzang, N., Weickhardt, A., Zhang, X.
Published 2022

Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues

by Chiaverini, L., Cirri, D., Corsi, F., Marrone, A., Marzo, T., Mendola, D.L, Piano, I., Pratesi, A., Tolbatov, I.
Published 2022

Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

by Bedard, P.L, Brohl, A.S, Cunningham, R., Giobbie-Hurder, A., Hathaway, E., Manos, M., Rahma, O.E, Renouf, D.J, Rodig, S., Severgnini, M., Sharon, E., Stephen Hodi, F., Streicher, H., Tyan, K.
Published 2022

Targeted Screening for Alzheimer's Disease Clinical Trials Using Data-Driven Disease Progression Models

by Alexander, D.C, Barkhof, F., Cash, D.M, For the Alzheimer's Disease Neuroimaging Initiative and the Alzheimer's Disease Cooperative Study, Oxtoby, N.P, Shand, C.
Published 2022

Social Media and COVID-19—Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics

by Bangalee, V., Bronkhorst, E., Ellero, A.A, Godman, B., Hendricks, C.L, Herd, C.L, Meyer, J.C, Myaka, T., Naidoo, E., Padayachee, N., Pepper, M.S, Schellack, N., Strydom, M., Truter, I.
Published 2022

Learning from COVID-19 related trial adaptations to inform efficient trial design—a sequential mixed methods study

by Burton, C., Cape, A., Chatters, R., Cooper, C.L, Lane, A., Murphy, C., O’Cathain, A., Sutherland, K., Tunnicliffe, L.
Published 2022

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

by Barro, C., Benkert, P., Chung, L., Daizadeh, N., Godin, J., Havari, E., Jacobs, A., Kaiser, C., Kappos, L., Kuhle, J., Leppert, D., Maceski, A., Michalak, Z., Mitchell, C.P, Rӧsch, N., Samad, T.A, Shankara, S., Sormani, M.P
Published 2022

A Bayesian adaptive phase I/II clinical trial design with late-onset competing risk outcomes

by Cao, S., Jin, I.H, Zang, Y., Zhang, C., Zhang, Y.
Published 2021